Spencer Guthrie is the founder of Attralus. Attralus has raised $201M in total funding. Latest round: Series B.
Spencer Guthrie is the CEO of Attralus, a clinical-stage biopharmaceutical company based in South San Francisco, California. He leads the company, founded in 2019, which focuses on developing pan-amyloid removal therapeutics for systemic amyloidosis.
Full founder directory · Investor directory · Company funding database · Fundraising library